85, 6% (82, 89) i henholdsvis de randomiserede Glivec - og IFN+Ara- C- grupper (p=0, 049, log- rank test).
85.6% (82, 89) in the randomised Glivec and the IFN+Ara-C groups, respectively (p=0.049, log-rank test).